Structure-guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion release. - Foster TL; Thompson GS; Kalverda AP; Kankanala J; Bentham M; Wetherill LF; Thompson J; Barker AM; Clarke D; Noerenberg M; Pearson AR; Rowlands DJ; et al. (Hepatology (Baltimore, Md.), 2014)